Institute of Biochemistry and Cell Biology, IBBC, CNR, Policlinico Umberto I, Rome, Italy.
Institute of Biochemistry and Cell Biology, IBBC, CNR, Monterotondo, Rome, Italy.
Pharmacol Res. 2021 Oct;172:105795. doi: 10.1016/j.phrs.2021.105795. Epub 2021 Jul 31.
Neuroinflammation can severely affect brain homeostasis and adult hippocampal neurogenesis with detrimental effects on cognitive processes. Brain and gut are intimately connected via the "gut-brain axis", a bidirectional communication system, and the administration of live bacteria (probiotics) has been shown to represent an intriguing approach for the prevention or even the cure of several diseases. In the present study we evaluated the putative neuroprotective effect of 15-days consumption of a multi-strain probiotic formulation based on food-associated strains and human gut bacteria at the dose of 10 CFU/mouse/day in a mouse model of acute inflammation, induced by an intraperitoneal single injection of LPS (0.1 mg/kg) at the end of probiotic administration. The results indicate that the prolonged administration of the multi-strain probiotic formulation not only prevents the LPS-dependent increase of pro-inflammatory cytokines in specific regions of the brain (hippocampus and cortex) and in the gastrointestinal district but also triggers a potent proneurogenic response capable of enhancing hippocampal neurogenesis. This effect is accompanied by a potentiation of intestinal barrier, as documented by the increased epithelial junction expression in the colon. Our hypothesis is that pre-treatment with the multi-strain probiotic formulation helps to create a systemic protection able to counteract or alleviate the effects of LPS-dependent acute pro-inflammatory responses.
神经炎症会严重影响大脑内环境稳态和成年海马神经发生,对认知过程产生不利影响。大脑和肠道通过“肠脑轴”紧密相连,这是一个双向通讯系统,而活菌(益生菌)的给药已被证明是预防甚至治疗多种疾病的一种有趣方法。在本研究中,我们评估了一种多菌株益生菌配方在急性炎症模型中的潜在神经保护作用,该模型通过在益生菌给药结束时腹腔内单次注射 LPS(0.1mg/kg)诱导。多菌株益生菌配方的长期给药不仅可以预防 LPS 依赖性增加大脑特定区域(海马体和皮质)和胃肠道中促炎细胞因子的增加,还可以引发强烈的促神经发生反应,从而增强海马神经发生。这种作用伴随着肠道屏障的增强,这在结肠中上皮连接表达的增加中得到证实。我们的假设是,多菌株益生菌配方的预处理有助于建立一种全身保护机制,能够对抗或减轻 LPS 依赖性急性促炎反应的影响。